Normothermic cardiopulmonary bypass increases heparin requirements necessary to maintain anticoagulation

被引:3
|
作者
Ereth, MH [1 ]
Fisher, BR [1 ]
Cook, DJ [1 ]
Nuttall, GA [1 ]
Orszulak, TA [1 ]
Oliver, WC [1 ]
机构
[1] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
关键词
heparin; anticoagulation; cardiopulmonary bypass; temperature; normothermia; hypothermia;
D O I
10.1023/A:1009987505590
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. With the practice of warm cardiopulmonary bypass (CPB) at our institution we have observed an apparent increase in heparin requirements. CPB temperature predictability affects pharmacokinetics and differences in drug metabolism can be expected. We hypothesized that heparin requirements would increase with increasing CPB temperature. Methods. Following Institutional Review Board approval, we reviewed the charts of 354 patients undergoing primary coronary artery bypass graft surgery. We recorded patient demographic data, CPB duration, heparin requirements, and temperature during CPB. CPB was conducted between 24 degrees C and 37 degrees C. The Spearman's correlation coefficient, Pearson chi-square, and rank-sum tests were used for data analysis. Results. Core temperature during CPB correlated with heparin requirements (r = 0.13, p < 0.02). However, CPB duration was shorter in warm patients than in cold patients (r = -0.455, p < 0.0001). Additional heparin requirements adjusted for duration of CPB (units/minute) were also significantly greater in the warm group (p = 0.018). Conclusions. Maintenance of adequate heparin anticoagulation during CPB is clinically important. Warm CPB patients required more heparin per minute than those undergoing cold CPB, More frequent assessment of anticoagulation and administration of additional heparin should be considered in patients undergoing warm CPB.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [31] Heparin induced thrombocytopenia and cardiopulmonary bypass strategy for cardiac surgery: which anticoagulation in 2009?
    Durand, Marion
    Devignes, Jean
    Hacquard, Marie
    Perrin, Julien
    Hirschi, Marie
    Carteaux, Jean-Pierre
    Lecompte, Thomas
    SANG THROMBOSE VAISSEAUX, 2009, 21 (02): : 71 - 77
  • [32] The Use of Bivalirudin for Cardiopulmonary Bypass Anticoagulation in Pediatric Heparin-Induced Thrombocytopenia Patients
    Gates, Richard
    Yost, Paul
    Parker, Beth
    ARTIFICIAL ORGANS, 2010, 34 (08) : 667 - U2
  • [33] Exploring Novel Aptamer-Heparin Combinations to Improve Anticoagulation Therapy in Cardiopulmonary Bypass
    Chabata, Charlene V.
    Gunaratne, Ruwan
    Frederiksen, James W.
    Sullenger, Bruce A.
    MOLECULAR THERAPY, 2019, 27 (04) : 364 - 365
  • [34] Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass (vol 16, pg 411, 2001)
    von Segesser, LK
    PERFUSION-UK, 2002, 17 (02): : 158 - 158
  • [35] HEPARIN-FREE CARDIOPULMONARY BYPASS - 1ST REPORTED USE OF HEPARINOID (ORG 10172) TO PROVIDE ANTICOAGULATION FOR CARDIOPULMONARY BYPASS
    DOHERTY, DC
    ORTEL, TL
    DEBRUIJN, N
    GREENBERG, CS
    VANTRIGT, P
    ANESTHESIOLOGY, 1990, 73 (03) : 562 - 565
  • [37] Neuropsychologic outcome after normothermic cardiopulmonary bypass
    Black, AMS
    Birdi, I
    Bryan, AJ
    Angelini, GD
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (01): : 146 - 147
  • [38] Minimum hematocrit for normothermic cardiopulmonary bypass in dogs
    Cook, DJ
    Orszulak, TA
    Daly, RC
    MacVeigh, I
    CIRCULATION, 1997, 96 (09) : 200 - 204
  • [39] Normothermic cardiopulmonary bypass in a patient with moyamoya disease
    Han, SH
    Kim, SD
    Ham, BM
    Kim, CS
    Bahk, JH
    Lim, C
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2005, 19 (04) : 499 - 500
  • [40] Effects of normothermic cardiopulmonary bypass on bispectral index
    Hirschi, M
    Meistelman, C
    Longrois, D
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2000, 17 (08) : 499 - 505